Page 21 - Eng Eong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

December 30, 2020 Reuters file BEIJING/SINGAPORE - An affiliate of China’s state-owned drug maker Sinopharm said on Wednesday its Covid-19 vaccine showed 79.34per cent efficacy and it has requested regulatory approval of the shot, moving a step closer to become China’s first approved vaccine for general public use. The efficacy rate, based on an interim analysis of Phase III clinical trials, is lower than 86per cent rate for the same vaccine announced by the United Arab Emirates on Dec. 9, based on preliminary data from trials there. A spokeswoman declined to explain the discrepancy and ...

Posted on 3643 Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT)reported approval from the Singapore Health Sciences Authority to commence its Phase 2 clinical study of its vaccine candidate ARCT-021.  The study will utilize its favorable phase ½ study results, including supportive preclinical data.  “We are pleased to advance ARCT-021 into a Phase 2 study based upon our promising Phase 1/2 data, which continues to support the potential for Arcturus’ STARR™ self-replicating mRNA technology to provide a highly effective, a...

Amid growing concerns about a new strain of the coronavirus surfacing here, experts have said measures now in place, such as wearing masks and social distancing, are sufficient to combat its spread.

SINGAPORE - Amid growing concerns about a new strain of the coronavirus surfacing here, experts have said measures now in place, such as wearing masks and social distancing, are sufficient to combat its spread. Two new strains of the disease have been discovered, in Britain and South Africa. Malaysia's Health Ministry has also identified a new strain from samples taken...

Amid growing concerns about a new strain of the coronavirus surfacing here, experts have said measures now in place, such as wearing masks and social distancing, are sufficient to combat its spread.. Read more at straitstimes.com.